The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
- Investigator
- Anita Rajasekhar
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
About me
Dr. Rajasekhar is a clinician and clinical investigator with a focus on benign hematology, specifically thrombosis and hemostasis. She is a member of the American Society of Hematology and the Hemostasis and Thrombosis Research Society.
My Locations
Active clinical trials
- Investigator
- Anita Rajasekhar
- Status
- Accepting Candidates
My research
Top areas of exploration
- Venous Thromboembolism , 15 publications
- Anticoagulants , 9 publications
- Pulmonary Embolism , 8 publications
- Hematology , 6 publications
Research activity
Accepted insurances
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMy areas of focus
Stories and news
Amazing Grace: Paratriathlete Grace Norman鈥檚 Pursuit of Gold With Help From BOB体育
Fitted for her first prosthetic leg at just 13 months old, it鈥檚 hard to fathom how many times in her life Grace Norman has put one on and taken one off. After鈥�
A Role Model for Hemophiliacs
Growing up the son of a football coach, Brett Sherman always had a love for sports, especially football. However, being born with hemophilia, a condition where鈥�
